Advanced Oncotherapy (FRA:R3I1) Net Margin % : 0.00% (As of Jun. 2022)

Advanced Oncotherapy Net Margin % Chart

Advanced Oncotherapy Annual Data
	Trend	Dec12	Dec13	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21
Net Margin %		Get a 7-Day Free Trial					-	-	-	-	-

Advanced Oncotherapy Semi-Annual Data
	Dec12	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22
Net Margin %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Advanced Oncotherapy's Net Margin %

For the Medical Devices subindustry, Advanced Oncotherapy's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Advanced Oncotherapy's Net Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Advanced Oncotherapy's Net Margin % distribution charts can be found below:

* The bar in red indicates where Advanced Oncotherapy's Net Margin % falls into.

Advanced Oncotherapy Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Advanced Oncotherapy's Net Margin for the fiscal year that ended in Dec. 2021 is calculated as

Advanced Oncotherapy's Net Margin for the quarter that ended in Jun. 2022 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Advanced Oncotherapy  (FRA:R3I1) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Advanced Oncotherapy Net Margin % Related Terms

Thank you for viewing the detailed overview of Advanced Oncotherapy's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Advanced Oncotherapy (FRA:R3I1) Business Description